Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Prev Med Public Health ; 56(2): 164-171, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37055358

RESUMEN

OBJECTIVES: Sarcopenia has emerged as a significant aging-related disease that affects many facets of societal-level and patient-level public health. This study analysed knowledge of sarcopenia and associated socio-demographic factors among the general public of Malaysia in order to effectively improve its prevention and countermeasures. METHODS: A cross-sectional online survey was conducted in Selangor, Malaysia, using Google Forms among 202 Malaysian adults from January 1, 2021 to March 31, 2021. Descriptive statistics were used to analyse the socio-demographic characteristics and knowledge scores. The continuous variables were evaluated using the independent t-test, Mann-Whitney test, and one-way analysis of variance test. The Spearman correlation coefficient was employed to determine the correlation between socio-demographic characteristics and knowledge score levels. RESULTS: The final analysis included 202 participants. The mean±standard deviation age was 49.03±12.65. Only 6.9% of participants had good knowledge of sarcopenia and were aware of sarcopenia's characteristics, consequences, and treatments. Post-hoc comparisons using the Dunnett T3 test showed statistical significance in mean knowledge score and age group (p=0.011) and education level (p≤0.001). The Mann-Whitney test revealed that gender (p=0.026) and current smoking status (p=0.023) significantly influenced knowledge scores. CONCLUSIONS: The general public's knowledge of sarcopenia was found to be poor to moderate and associated with age and education status. Therefore, education and interventions by policymakers and healthcare professionals to improve public knowledge of sarcopenia in Malaysia are needed.


Asunto(s)
Sarcopenia , Adulto , Humanos , Estudios Transversales , Encuestas y Cuestionarios , Escolaridad , Pueblo Asiatico , Conocimientos, Actitudes y Práctica en Salud
2.
Scand J Clin Lab Invest ; 81(2): 147-159, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33528280

RESUMEN

The pathogenesis involving non-alcoholic fatty liver disease (NAFLD) in the context of chronic HBV (CHB) virus infection requires to be understood for developing improved modalities of diagnosis and treatment. We retrospectively investigated the association between NAFLD and CHB virus infection in the context of liver fibrosis. Among the 522 consecutive CHB patients who underwent transient elastography between years 2013 and 2016, we studied 455 subjects in the current investigation. Controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) scores were generally higher in patients with steatosis and fibrosis or cirrhosis. Antiviral treatment had significantly reduced the hepatitis B virus (HBV) viral load. Other liver function markers showed a significant positive correlation with both CAP and LSM scores. Plasma IL-13 was independently associated with increased CAP score where every increase of 1 unit of IL-13 was associated with an increase in CAP score by 0.98 unit. CCL11 was independently associated with LSM with every increase of CCL11 by a unit that, in turn, was associated with an increase of LSM score. We found that there was a high concurrence of NAFLD among patients with CHB virus infection. The presence of metabolic syndrome and chronic inflammation in CHB virus-infected patients were two independent factors that led to the progression of liver cirrhosis, with IL-13 playing the key role in linking the metabolic with the inflammatory components.


Asunto(s)
Quimiocina CCL11/sangre , Hígado Graso/sangre , Hepatitis B Crónica/sangre , Inflamación/patología , Interleucina-13/sangre , Cirrosis Hepática/sangre , Adulto , Biomarcadores/sangre , Fenómenos Biomecánicos , ADN Viral/sangre , Diabetes Mellitus/sangre , Hígado Graso/complicaciones , Hígado Graso/metabolismo , Hígado Graso/fisiopatología , Femenino , Factor Estimulante de Colonias de Granulocitos/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Virus de la Hepatitis B/fisiología , Hepatitis B Crónica/complicaciones , Hepatitis B Crónica/fisiopatología , Humanos , Inflamación/complicaciones , Hígado/fisiopatología , Cirrosis Hepática/complicaciones , Cirrosis Hepática/fisiopatología , Masculino , Persona de Mediana Edad , Recuento de Plaquetas
3.
J Med Invest ; 56(1-2): 6-10, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19262007

RESUMEN

Hyperglycemia and insulin resistance are common in many critically ill patients. Hyperglycemia increases the production of reactive oxygen species in cells, stimulates the production of the potent proinflammatory cytokines IL-8 and TNF-alpha, and enhances the expression of haem oxygenase-1, an inducible stress protein. It has been shown that administration of insulin and the semi-essential amino acid glutamine have been beneficial to the septic patient. The aim of our study is to test whether these two molecules, glutamine and insulin used in combination attenuate the proinflammatory responses in endothelial cells which have been triggered by hyperglycaemia. Our results demonstrate that a combination of insulin and glutamine are significantly more effective in reducing the expression of IL-8, TNF-alpha and HO-1 than insulin or glutamine alone.


Asunto(s)
Endotelio Vascular/metabolismo , Hiperglucemia/metabolismo , Inflamación/metabolismo , Estrés Oxidativo/fisiología , Células Cultivadas , Quimioterapia Combinada , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Glutamina/farmacología , Glutamina/uso terapéutico , Hemo-Oxigenasa 1/metabolismo , Humanos , Hiperglucemia/tratamiento farmacológico , Hipoglucemiantes/farmacología , Hipoglucemiantes/uso terapéutico , Inflamación/tratamiento farmacológico , Insulina/farmacología , Insulina/uso terapéutico , Interleucina-8/metabolismo , Modelos Biológicos , Estrés Oxidativo/efectos de los fármacos , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA